Opinion
Case No. C 09-2145 (EMC)
10-17-2011
ONYX PHARMACEUTICALS, INC., Plaintiff, v. BAYER CORPORATION, BAYER AG, BAYER HEALTHCARE LLC, AND BAYER SCHERING PHARMA AG, Defendants.
Martin S. Schenker Attorneys for Plaintiff ONYX PHARMACEUTICALS, INC. BARTLIT BECK HERMAN PALENCHAR & SCOTT LLP J. Scott McBride Attorneys for Defendants BAYER CORPORATION; BAYER HEALTHCARE LLC; BAYER. AG; BAYER SCHERING PHARMA AG
COOLEY LLP
Stephen C. Neal (170085)
(nealsc@cooley.com)
Michelle S. Rhyu, PH.D. (212922)
(rhyums@cooley.com)
Bryan J. Boyle (253725)
(bryan.boyle@cooley.com)
Daniel J. Knauss (267414)
(dknauss@cooley.com)
Five Palo Alto Square
3000 El Camino Real
Palo Alto, CA 94306-2155
Telephone: (650) 843-5000
Facsimile: (650) 857-0663
COOLEY LLP
Martin S. Schenker (109828)
(mschenker@cooley.com)
Benjamin H. Kleine (257225)
(bkleine@cooley.com)
101 California Street, 5th Floor
San Francisco, CA 94111-5800
Telephone: (415) 693-2000
Facsimile: (415) 693-2222
Attorneys for Plaintiff
ONYX PHARMACEUTICALS, INC.
MORRISON & FOERSTER LLP
Alison M. Tucher (171363)
(atucher@mofo. com)
Amy C. Dachtler (248589)
(adachtler@mofo. com)
425 Market Street
San Francisco, CA 94105-2482
Tel: (415) 268-7000
Fax: (415) 268 7522
BARTLIT BECK HERMAN PALENCHAR
& SCOTT LLP
Philip S. Beck(admitted pro hac vice)
(philip.beck@bartlit-beck. com)
Mark Levine (admitted pro hac vice)
(mark.levine@bartlit-beck.com)
Jason L. Peltz (admitted pro hac vice)
(jason.peltz@bartlit-beck.com)
James B. Heaton, III (admitted pro hac vice)
(jb.heaton@bartlit-beck.com)
Brian C. Swanson (admitted pro hac vice)
(brian.swanson@bartlit-beck.com)
J. Scott McBride (admitted pro hac vice)
(scott.mcbride@bartlit-beck.com)
54 West Hubbard Street, Suite 300
Chicago, IL 60654
Tel: (312) 494-4400
Fax: (312) 494-4440
Attorneys for Defendants BAYER
CORPORATION; BAYER HEALTHCARE
LLC; BAYER AG; BAYER SCHERING
PHARMA AG
STIPULATION AND [PROPOSED]
ORDER REQUESTING DISMISSAL
Hon. Edward M. Chen
Pursuant to a settlement agreement entered into by the parties in the above-entitled action, and pursuant to Rule 41(a) of the Federal Rules of Civil Procedure, the parties hereby stipulate and request that the Court DISMISS WITH PREJUDICE all claims between the parties in the above-entitled action, each party to bear its own costs and attorneys' fees.
Pursuant to the terms of the settlement agreement, the parties further stipulate and request that the Court retain jurisdiction over the above-entitled action and over the parties personally for the purposes of enforcing the payment obligation set forth in Section 12 of the Fourth Amendment to the Collaboration Agreement between the parties.
COOLEY LLP
Martin S. Schenker
Attorneys for Plaintiff
ONYX PHARMACEUTICALS, INC.
BARTLIT BECK HERMAN PALENCHAR
& SCOTT LLP
J. Scott McBride
Attorneys for Defendants
BAYER CORPORATION; BAYER
HEALTHCARE LLC; BAYER. AG; BAYER
SCHERING PHARMA AG
PURSUANT TO STIPULATION, IT IS SO ORDERED.
Hon. Edward M. Chen
ATTESTATION PURSUANT TO GENERAL ORDER 45
I, Martin S. Schenker, attest that concurrence in the filing of this Stipulation And [Proposed] Order Requesting Dismissal has been obtained from each of the other signatories. Executed this 14th day of October, 2011, at San Francisco, California.
Martin S. Schenker